Peer-reviewed veterinary case report
Canine status epilepticus: a translational platform for human therapeutic trials.
- Journal:
- Epilepsia
- Year:
- 2011
- Authors:
- Leppik, Ilo E et al.
- Affiliation:
- Department of Experimental & Clinical Pharmacology · United States
- Species:
- dog
Abstract
Current treatment of human status epilepticus (SE) relies on drugs developed for chronic treatment of epilepsy. Many potent compounds have been discovered in animal models of SE. But they may never be useful for chronic treatment of epilepsy and thus not available for human use. Naturally occurring canine SE may become a translational platform for evaluating these compounds for eventual use in human trials. A pilot study of levetiracetam in canine SE demonstrated a 56% response rate compared to 10% for placebo. Based on these results we have obtained an NIH R-21 to further evaluate canine SE as a translational platform for developing new approaches for treating human SE.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/21967357/